Depression
Feature
Specialty and age may contribute to suicidal thoughts among physicians
“The specialties with the highest reporting of physician suicidal thoughts are also those with the greatest physician shortages.”
News
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...
From the Journals
Distinct suicidal thought patterns flag those at highest risk
New research indicates that ideation and cognition “may act as independent risk factors for suicidal behavior.”
From the Journals
Encephalitis linked to psychosis, suicidal thoughts
“The clinical care of persons with encephalitis is challenging because these patients suffer from acute and severe mental health disturbances,”...
From the Journals
Thyroid hormones predict psychotic depression in MDD patients
Regular thyroid function tests may help with early identification and intervention of PD.
From the Journals
Beyond the psychedelic effect: Ayahuasca as antidepressant
Some acute measures assessed during ayahuasca dosing moderated the improvements in MDD biomarkers 2 days after a treatment session.
From the Journals
Statin disappoints for treatment-resistant depression
“Clinical trials of other statins ... have also been congruent with our results,” said Dr. M. Ishrat Husain.
Commentary
What’s new in brain health?
A new study shows that nonmedical treatment is effective in people with frequent episodic and chronic tension-type headache.
From the Journals
‘Sighing’ tops mindfulness for reduced stress, improved mood
Controlled breathwork has emerged as a potential tool to manage stress and boost well-being.
Feature
Time for a national ketamine registry, experts say
Support is growing for the creation of a ketamine registry to collect data on dosage, treatment frequency, adverse events, and long-term outcomes...
From the Journals
Repetitive TMS effective for comorbid depression, substance use
“I suspect this is just the beginning of a new era in neuromodulation-based therapeutics for people struggling with drug and alcohol use disorders...